3H Healthcare Investment
Deal focus: Chamlion leaves its mark on 3D printing
The dental industry was one of few areas in which China’s army of 3D printing start-ups found sufficient addressable demand. Chamlion has risen to the top of the pile by virtue of a timely services pivot
China RNA vaccine developer raises $42m
Therorna, a China-based biotech company specializing in vaccines and drugs based on circular RNA technology, has raised USD 42m in Series A funding.
3H Healthcare closes second US dollar fund at $330m
3H Healthcare Investment, which specializes in early-stage China biotech and medical devices deals, has closed its second US dollar-denominated fund at the hard cap of $330 million.